Back to results
US 2018/0008588 A1Published application
Antihistamine for use in treatment of breast cancer
AssigneeBelina Pharma AB
InventorsHakan OLSSON, Rickard EINEFORS
Life of this patent
Estimating the term…
Abstract
Disclosed herein is desloratadine or ebastin for use in treatment of a patient diagnosed with breast cancer. Also disclosed is desloratadine or ebastin for use in treatment of a patient diagnosed with a cancer type susceptible to immunotherapy.
Claims15
A method of treating breast cancer in a patient, the method comprising administering to the patient an effective amount of desloratadine or ebastin.
A method of treating cancer of a type susceptible to immunotherapy in a patient, the method comprising administering to the patient an effective amount of desloratadine or ebastin.
Dependencies are inferred from the claim text.